Redhill Biopharma Ltd - Asset Resilience Ratio

Latest as of March 2025: 14.88%

Redhill Biopharma Ltd (RDHL) has an Asset Resilience Ratio of 14.88% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Redhill Biopharma Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$2.73 Million

Cash + Short-term Investments

Total Assets

$18.38 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Redhill Biopharma Ltd's Asset Resilience Ratio has changed over time. See net assets of Redhill Biopharma Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Redhill Biopharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RDHL market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.73 Million	14.88%
Total Liquid Assets	$2.73 Million	14.88%

Asset Resilience Insights

Moderate Liquidity: Redhill Biopharma Ltd has 14.88% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Redhill Biopharma Ltd Industry Peers by Asset Resilience Ratio

Compare Redhill Biopharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Redhill Biopharma Ltd (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Redhill Biopharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.16%	$2.73 Million	$18.04 Million	+11.73pp
2023-12-31	3.43%	$790.04K	$23.05 Million	+3.42pp
2022-12-31	0.01%	$15.00K	$158.87 Million	-4.70pp
2021-12-31	4.71%	$8.53 Million	$181.19 Million	+4.43pp
2020-12-31	0.28%	$498.00K	$180.24 Million	-25.16pp
2019-12-31	25.44%	$18.85 Million	$74.10 Million	-13.31pp
2018-12-31	38.74%	$24.18 Million	$62.41 Million	-13.14pp
2017-12-31	51.88%	$29.75 Million	$57.34 Million	+35.22pp
2016-12-31	16.67%	$12.37 Million	$74.21 Million	-38.13pp
2015-12-31	54.80%	$36.62 Million	$66.83 Million	-4.30pp
2014-12-31	59.10%	$17.05 Million	$28.86 Million	+57.27pp
2013-12-31	1.83%	$262.00K	$14.34 Million	-5.89pp
2012-12-31	7.72%	$1.55 Million	$20.10 Million	-14.96pp
2011-12-31	22.67%	$4.58 Million	$20.19 Million	+22.53pp
2010-12-31	0.14%	$15.00K	$10.51 Million	--

pp = percentage points

About Redhill Biopharma Ltd

NASDAQ:RDHL USA Drug Manufacturers - Specialty & Generic

Market Cap

$5.55 Million

Market Cap Rank

#28279 Global

#5572 in USA

Share Price

$1.09

Change (1 day)

-0.46%

52-Week Range

$0.74 - $2.52

All Time High

$16290.00